July 1, 2020 NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPANBayer issues new senior bonds with a volume of 6 billion eurosRead more
June 24, 2020 Investor Conference CallSPEECHESBayer announces agreements to resolve major legacy Monsanto litigationRead more
June 19, 2020 Not intended for U.S. and UK MediaBayer contributes an additional 50 million units of treatment to the World Federation of Hemophilia Humanitarian Aid ProgramRead more
June 19, 2020 Women empowerment in times of COVID-19Bayer supports “The Challenge Initiative” of Johns Hopkins Bloomberg School of Public Health with 10 million USDRead more
June 17, 2020 Bayer to Provide Crop Relief to Two Million Smallholder Farmers Impacted by COVID-19Read more
SPECIALIZED PRESS June 17, 2020 Not intended for U.S. and UK MediaBayer to highlight latest research on its advancing Oncology portfolio at the AACR20 Virtual Annual Meeting IIRead more
SPECIALIZED PRESS June 15, 2020 Not intended for U.S. and UK MediaBayer extends clinical development program for finerenone with Phase III study in patients with heart failure and preserved ejection fractionRead more
SPECIALIZED PRESS June 5, 2020 Not intended for U.S. and UK MediaBayer submits vericiguat for marketing authorization in the EU and Japan for the treatment of chronic heart failureRead more
.jpg)
